• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

协调 tau 正电子发射断层扫描在阿尔茨海默病中的应用:CenTauR 量表和联合传播模型。

Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model.

机构信息

Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.

Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA.

出版信息

Alzheimers Dement. 2024 Sep;20(9):5833-5848. doi: 10.1002/alz.13908. Epub 2024 Jul 23.

DOI:10.1002/alz.13908
PMID:39041435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11497758/
Abstract

INTRODUCTION

Tau-positron emission tomography (PET) outcome data of patients with Alzheimer's disease (AD) cannot currently be meaningfully compared or combined when different tracers are used due to differences in tracer properties, instrumentation, and methods of analysis.

METHODS

Using head-to-head data from five cohorts with tau PET radiotracers designed to target tau deposition in AD, we tested a joint propagation model (JPM) to harmonize quantification (units termed "CenTauR" [CTR]). JPM is a statistical model that simultaneously models the relationships between head-to-head and anchor point data. JPM was compared to a linear regression approach analogous to the one used in the amyloid PET Centiloid scale.

RESULTS

A strong linear relationship was observed between CTR values across brain regions. Using the JPM approach, CTR estimates were similar to, but more accurate than, those derived using the linear regression approach.

DISCUSSION

Preliminary findings using the JPM support the development and adoption of a universal scale for tau-PET quantification.

HIGHLIGHTS

Tested a novel joint propagation model (JPM) to harmonize quantification of tau PET. Units of common scale are termed "CenTauRs". Tested a Centiloid-like linear regression approach. Using five cohorts with head-to-head tau PET, JPM outperformed linearregressionbased approach. Strong linear relationship was observed between CenTauRs values across brain regions.

摘要

简介

由于示踪剂特性、仪器设备和分析方法的差异,当使用不同示踪剂时,阿尔茨海默病(AD)患者的 Tau 正电子发射断层扫描(PET)结果数据目前无法进行有意义的比较或合并。

方法

使用针对 AD 中 Tau 沉积的五种 Tau PET 放射性示踪剂的头对头数据,我们测试了联合传播模型(JPM)以协调定量(称为“CenTauR”[CTR]的单位)。JPM 是一种统计模型,可同时模拟头对头和锚点数据之间的关系。JPM 与类似于在淀粉样蛋白 PET Centiloid 量表中使用的线性回归方法进行了比较。

结果

在大脑区域之间观察到 CTR 值之间存在很强的线性关系。使用 JPM 方法,CTR 估计值与使用线性回归方法得出的估计值相似,但更准确。

讨论

使用 JPM 的初步发现支持开发和采用 Tau-PET 定量的通用量表。

要点

测试了一种新的联合传播模型(JPM)来协调 Tau PET 的定量。共同量表的单位称为“CenTauRs”。测试了类似于 Centiloid 的线性回归方法。使用五个具有 Tau PET 头对头的队列,JPM 优于基于线性回归的方法。在大脑区域之间观察到 CenTauRs 值之间存在很强的线性关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/a021b30320b2/ALZ-20-5833-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/8cb26b6fe28a/ALZ-20-5833-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/b3a80fd4959a/ALZ-20-5833-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/6b6426201425/ALZ-20-5833-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/7ed3253a1d2f/ALZ-20-5833-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/a021b30320b2/ALZ-20-5833-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/8cb26b6fe28a/ALZ-20-5833-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/b3a80fd4959a/ALZ-20-5833-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/6b6426201425/ALZ-20-5833-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/7ed3253a1d2f/ALZ-20-5833-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9410/11497758/a021b30320b2/ALZ-20-5833-g004.jpg

相似文献

1
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model.协调 tau 正电子发射断层扫描在阿尔茨海默病中的应用:CenTauR 量表和联合传播模型。
Alzheimers Dement. 2024 Sep;20(9):5833-5848. doi: 10.1002/alz.13908. Epub 2024 Jul 23.
2
Head-to-head comparison of tau PET tracers [F]PI-2620 and [F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort.在有脑淀粉样蛋白沉积的非痴呆个体中,tau PET 示踪剂[F]PI-2620 和 [F]RO948 的头对头比较:TAU-PET FACEHBI 队列。
Alzheimers Res Ther. 2024 Nov 28;16(1):257. doi: 10.1186/s13195-024-01622-5.
3
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.Tau 正电子发射断层扫描作为临床前和前驱期阿尔茨海默病预后标志物的准确性:与淀粉样蛋白正电子发射断层扫描和磁共振成像的头对头比较。
JAMA Neurol. 2021 Aug 1;78(8):961-971. doi: 10.1001/jamaneurol.2021.1858.
4
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.RO948 F 18 tau 正电子发射断层扫描在阿尔茨海默病与其他神经退行性疾病鉴别诊断中的性能。
JAMA Neurol. 2020 Aug 1;77(8):955-965. doi: 10.1001/jamaneurol.2020.0989.
5
In Vivo Head-to-Head Comparison of [F]GTP1 with [F]MK-6240 and [F]PI-2620 in Alzheimer Disease.[F]GTP1与[F]MK-6240和[F]PI-2620在阿尔茨海默病中的体内直接比较
J Nucl Med. 2025 Feb 3;66(2):277-285. doi: 10.2967/jnumed.124.268623.
6
[F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease.[F]GTP1(基因泰克 Tau 探针 1),一种用于检测阿尔茨海默病神经纤维缠结 Tau 病理学的放射性配体。
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2077-2089. doi: 10.1007/s00259-019-04399-0. Epub 2019 Jun 28.
7
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.18F-氟托西匹 PET 与阿尔茨海默病和其他神经退行性疾病的尸检比较。
Brain. 2020 Dec 5;143(11):3477-3494. doi: 10.1093/brain/awaa276.
8
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
9
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.18F-MK-6240 tau 缠结的纵向积累遵循 Braak 分期。
Brain. 2021 Dec 16;144(11):3517-3528. doi: 10.1093/brain/awab248.
10
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.基于生物标志物的阿尔茨海默病纵向 Tau 正电子发射断层扫描预测。
JAMA Neurol. 2022 Feb 1;79(2):149-158. doi: 10.1001/jamaneurol.2021.4654.

引用本文的文献

1
Recent advances in neuroimaging of Alzheimer's disease and related dementias.阿尔茨海默病及相关痴呆症神经影像学的最新进展。
Alzheimers Dement. 2025 Sep;21(9):e70648. doi: 10.1002/alz.70648.
2
The Mobile Toolbox for remote, self-administered cognitive assessment in older adults: associations with in-clinic cognitive testing and Alzheimer's disease biomarkers.老年人远程自我管理认知评估移动工具箱:与门诊认知测试及阿尔茨海默病生物标志物的关联
Alzheimers Dement (Amst). 2025 Aug 19;17(3):e70160. doi: 10.1002/dad2.70160. eCollection 2025 Jul-Sep.
3
Advances in PET imaging of protein aggregates associated with neurodegenerative disease.

本文引用的文献

1
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).早发性 AD 的淀粉样蛋白和 tau-PET:来自纵向早发性阿尔茨海默病研究(LEADS)的基线数据。
Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S98-S114. doi: 10.1002/alz.13453. Epub 2023 Sep 10.
2
Improving quantification by correcting for radiotracer clearance in tissue.通过校正组织中的放射性示踪剂清除率来改善定量分析。
J Cereb Blood Flow Metab. 2024 Feb;44(2):296-309. doi: 10.1177/0271678X231196804. Epub 2023 Aug 17.
3
CenTauR: Toward a universal scale and masks for standardizing tau imaging studies.
与神经退行性疾病相关的蛋白质聚集体的正电子发射断层扫描(PET)成像进展。
Nat Rev Neurol. 2025 Aug 11. doi: 10.1038/s41582-025-01126-2.
4
A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies.疾病修饰疗法时代阿尔茨海默病药物研发宣言。
Mol Neurodegener. 2025 Aug 6;20(1):88. doi: 10.1186/s13024-025-00872-7.
5
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex.有认知障碍和无认知障碍个体的Tau正电子发射断层扫描(PET)阳性率随年龄、淀粉样蛋白-β状态、载脂蛋白E(APOE)基因型和性别而变化。
Nat Neurosci. 2025 Jul 16. doi: 10.1038/s41593-025-02000-6.
6
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [F]flortaucipir imaging: TAU-SPEX.作为[F]氟替卡匹尔成像视觉解读潜在辅助手段的PET空间范围定量分析:TAU-SPEX。
Eur J Nucl Med Mol Imaging. 2025 Jun 7. doi: 10.1007/s00259-025-07384-y.
7
Biomarker-guided decision making in clinical drug development for neurodegenerative disorders.神经退行性疾病临床药物研发中的生物标志物引导决策
Nat Rev Drug Discov. 2025 Apr 4. doi: 10.1038/s41573-025-01165-w.
8
Exploring the origins of frequent tau-PET signal in vermal and adjacent regions.探索蚓部及相邻区域tau正电子发射断层扫描(PET)信号频繁出现的起源。
Eur J Nucl Med Mol Imaging. 2025 Mar 18. doi: 10.1007/s00259-025-07199-x.
9
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers.阿尔茨海默病神经病理学及其通过体液和影像生物标志物进行的评估。
Mol Neurodegener. 2025 Mar 14;20(1):33. doi: 10.1186/s13024-025-00819-y.
10
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis.临床前阿尔茨海默病纵向tau正电子发射断层扫描中的性别差异:一项荟萃分析。
JAMA Neurol. 2025 Mar 3;82(4):364-75. doi: 10.1001/jamaneurol.2025.0013.
CenTauR:迈向用于标准化tau成像研究的通用量表和掩膜。
Alzheimers Dement (Amst). 2023 Jul 7;15(3):e12454. doi: 10.1002/dad2.12454. eCollection 2023 Jul-Sep.
4
Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms.tau 正电子发射断层扫描在认知症状患者诊断中的临床效用。
JAMA Neurol. 2023 Jul 1;80(7):749-756. doi: 10.1001/jamaneurol.2023.1323.
5
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.比较群组水平和个体化脑区在阿尔茨海默病纵向 Tau 正电子发射断层扫描中测量变化的价值。
JAMA Neurol. 2023 Jun 1;80(6):614-623. doi: 10.1001/jamaneurol.2023.1067.
6
Development, initial validation, and application of a visual read method for [F]MK-6240 tau PET.[F]MK-6240 tau正电子发射断层显像(PET)视觉读取方法的开发、初步验证及应用
Alzheimers Dement (N Y). 2023 Feb 12;9(1):e12372. doi: 10.1002/trc2.12372. eCollection 2023 Jan-Mar.
7
Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL F-MK6240 PET study.衰老过程中和阿尔茨海默病连续体中区域 tau 积累的速率:AIBL F-MK6240 PET 研究。
EBioMedicine. 2023 Feb;88:104450. doi: 10.1016/j.ebiom.2023.104450. Epub 2023 Jan 27.
8
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.淀粉样蛋白和 tau 正电子发射断层扫描(PET)阳性、认知正常的个体未来认知能力下降的风险较高。
Nat Med. 2022 Nov;28(11):2381-2387. doi: 10.1038/s41591-022-02049-x. Epub 2022 Nov 10.
9
A Visual Interpretation Algorithm for Assessing Brain Tauopathy with F-MK-6240 PET.F-MK-6240 PET 评估脑 Tau 病的可视化解读算法。
J Nucl Med. 2023 Mar;64(3):444-451. doi: 10.2967/jnumed.122.264371. Epub 2022 Sep 29.
10
Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial.度胺能减少淀粉样蛋白后与 tau 病理和临床结局的关联:TRAILBLAZER-ALZ 随机临床试验。
JAMA Neurol. 2022 Oct 1;79(10):1015-1024. doi: 10.1001/jamaneurol.2022.2793.